The start of a so-called rolling review formally begins an FDA evaluation of a closely watched drug that’s important to the biotech’s future, but faces questions about its sales potential.
Vertex Pharmaceuticals has inched closer to bringing a new, non-opioid med to the blockbuster pain market, with the FDA ...
Higher doses of Narcan — or naloxone — do not affect the possibility of survival after an overdose. Be cautious.
Narcan, a nasal spray variant of naloxone has been made available over the counter, a federal move that has since widened ...
LITTLE ROCK (KATV) — A new additional drug in the fight against the opioid overdose crisis has slowly been making its way across the country and it is now available right here in Arkansas, a ...
Some argue a need for more potent — and pricier — overdose reversal drugs; others frame that effort as drugmakers peddling ...
Physicians said the test is based “on old genetic studies that have largely been abandoned” and could exacerbate the opioid crisis.
When I started taking opioids, they were all I was taking. I’d always thought of medicine as a take-only-when-needed kind of ...
Purdue Pharma L.P. ("Purdue") announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection*. If ...
A group of 31 experts in genetics, addiction, psychiatry, and medical-device regulation sent letters to the FDA and Centers for Medicare and Medicaid Services, The Washington Post reported. The ...
The start of the opioid epidemic is ironically linked to a drug that was supposed to help people suffering from moderate to ...
Purdue Pharma has asked the federal Food and Drug Administration (FDA) to approve a new, auto-injectable form of one of its drugs to treat opioid overdoses. The Stamford-based biopharmaceutical ...